DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Omeprazole And Sodium Bicarbonate is a drug marketed by Ajanta Pharma Ltd, Aurolife Pharma Llc, Dr Reddys Labs Ltd, Guardian Drug, Par Pharm, Perrigo R And D, Sciegen Pharms Inc, Unicorn, and Zydus Pharms. and is included in fourteen NDAs.
The generic ingredient in OMEPRAZOLE AND SODIUM BICARBONATE is omeprazole; sodium bicarbonate. There are one hundred and thirty-one drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the omeprazole; sodium bicarbonate profile page.
Recent Clinical Trials for OMEPRAZOLE AND SODIUM BICARBONATE
Identify potential brand extensions & 505(b)(2) entrants
|Food and Drug Administration (FDA)||Phase 1|
|BioPharma Services, Inc||Phase 1|
|Ajou University School of Medicine||Phase 1|